Citation Impact
Citing Papers
Integrated Array-Comparative Genomic Hybridization and Expression Array Profiles Identify Clinically Relevant Molecular Subtypes of Glioblastoma
2005
Marked Genomic Differences Characterize Primary and Secondary Glioblastoma Subtypes and Identify Two Distinct Molecular and Clinical Secondary Glioblastoma Entities
2006
Cancer Stem Cell Analysis and Clinical Outcome in Patients with Glioblastoma Multiforme
2008
Cancer is a Preventable Disease that Requires Major Lifestyle Changes
2008 Standout
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
2008 StandoutNature
Astrocytes: biology and pathology
2009 Standout
Cancer Invasion and the Microenvironment: Plasticity and Reciprocity
2011 Standout
IDH1andIDH2Mutations in Gliomas
2009 Standout
Angiogenesis in primary central nervous system lymphoma (PCNSL)
2007
Bruxism physiology and pathology: an overview for clinicians*
2008 Standout
Impact of race/ethnicity on molecular pathways in human cancer
2004
A survey of MRI-based medical image analysis for brain tumor studies
2013 Standout
Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis
2006 Standout
Thymoquinone: Potential cure for inflammatory disorders and cancer
2011 Standout
Malignant astrocytic glioma: genetics, biology, and paths to treatment
2007 Standout
Research diagnostic criteria for temporomandibular disorders: a systematic review of axis I epidemiologic findings
2011 Standout
Thymoquinone and its therapeutic potentials
2015 Standout
Oral parafunctions as risk factors for diagnostic TMD subgroups
2009
Correlation Among Pathology, Genotype, and Patient Outcomes in Glioblastoma
2006
Bevacizumab may improve quality of life, but not overall survival in glioblastoma: an epidemiological study
2018
Arsenic trioxide induces autophagic cell death in malignant glioma cells by upregulation of mitochondrial cell death protein BNIP3
2004
Hypoxia and the extracellular matrix: drivers of tumour metastasis
2014 StandoutNobel
Virtues and woes of AChE alternative splicing in stress-related neuropathologies
2006
Relationship between bruxism and temporomandibular disorders: a systematic review of literature from 1998 to 2008
2010
Development, maintenance and disruption of the blood-brain barrier
2013 Standout
Malignant Gliomas in Adults
2008 Standout
Mitochondrial Membrane Permeabilization in Cell Death
2007 Standout
Histology-Based Expression Profiling Yields Novel Prognostic Markers in Human Glioblastoma
2005
Primary brain tumours in adults
2012 Standout
Autophagy in cell death: an innocent convict?
2005 Standout
Immunotherapy of Diffuse Gliomas: Biological Background, Current Status and Future Developments
2009 Standout
Effects of thymoquinone on isolated and cellular proteasomes
2010
Molecular imaging of brain tumors with 18F-DOPA PET and PET/CT
2012
Nuclear EGFRvIII‐STAT5b complex contributes to glioblastoma cell survival by direct activation of the Bcl‐XL promoter
2012
FcRn: the neonatal Fc receptor comes of age
2007 Standout
Relationships between craniofacial pain and bruxism*
2008
The role of matrix metalloproteinases in the pathophysiology and progression of human nervous system malignancies: a chance for the development of targeted therapeutic approaches?
2008
Long-term survival with glioblastoma multiforme
2007
Epidemiology of Bruxism in Adults: A Systematic Review of the Literature
2013 Standout
The 2007 WHO Classification of Tumours of the Central Nervous System
2007 Standout
Symptoms and Physiological Responses to Prolonged, Repeated, Low‐Level Tooth Clenching in Humans
2015
Management of glioblastoma: State of the art and future directions
2020 Standout
Amelioration of Experimental Autoimmune Myasthenia Gravis in Rats by Neonatal FcR Blockade
2007
New Strategies for Fluorescent Probe Design in Medical Diagnostic Imaging
2009 Standout
Nitrile-Containing Pharmaceuticals: Efficacious Roles of the Nitrile Pharmacophore
2010 Standout
Computationally designed high specificity inhibitors delineate the roles of BCL2 family proteins in cancer
2016 StandoutNobel
Longitudinal Multilevel Modeling of Facial Pain, Muscle Tension, and Stress
2016
Cimetidine, an unexpected anti-tumor agent, and its potential for the treatment of glioblastoma (review)
2006
Headache and Temporomandibular Disorders: Evidence for Diagnostic and Behavioural Overlap
2007
International consensus on the assessment of bruxism: Report of a work in progress
2018 Standout
Oral behaviors checklist: reliability of performance in targeted waking-state behaviors.
2006
The Versatile Role of microRNA-30a in Human Cancer
2017 Standout
The 2007 WHO Classification of Tumours of the Central Nervous System
2010 Standout
The prognostic relevance of molecular alterations in glioblastomas for patients age < 50 years
2005
Nonfunctional tooth contact in healthy controls and patients with myogenous facial pain.
2007
Unequivocal Delineation of Clinicogenetic Subgroups and Development of a New Model for Improved Outcome Prediction in Neuroblastoma
2005
Painful Temporomandibular Disorder
2016 Standout
Molecular targets of dietary agents for prevention and therapy of cancer
2006 Standout
Applications of Fluorine in Medicinal Chemistry
2015 Standout
Minimal experimental requirements for definition of extracellular vesicles and their functions: a position statement from the International Society for Extracellular Vesicles
2014 Standout
The International Neuroblastoma Risk Group (INRG) Classification System: An INRG Task Force Report
2008 Standout
Cost of Migration: Invasion of Malignant Gliomas and Implications for Treatment
2003
Epidemiologic and Molecular Prognostic Review of Glioblastoma
2014 Standout
Regulation of Mammalian Autophagy in Physiology and Pathophysiology
2010 Standout
Works of Eric Burton being referenced
Parafunctional Clenching, Pain, and Effort in Temporomandibular Disorders
2004
Hemorrhage and VEGF Expression in a Case of Primary CNS Lymphoma
2002
Malignant gliomas
2000
Management of Myasthenia Gravis
1972
Aberrant p53, mdm2, and proliferation differ in glioblastomas from long-term compared with typical survivors.
2002
Genetic aberrations defined by comparative genomic hybridization distinguish long-term from typical survivors of glioblastoma.
2002
Survival in elderly glioblastoma patients treated with bevacizumab-based regimens in the United States
2018